AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 86, Issue 5 734-737, Copyright © 1996 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weibel, R E
Right arrow Articles by Benor, D E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weibel, R E
Right arrow Articles by Benor, D E
Reporting vaccine-associated paralytic poliomyelitis: concordance between the CDC and the National Vaccine Injury Compensation Program.

R E Weibel and D E Benor

National Vaccine Injury Compensation Program, Health Resources and Services Administration, Rockville, Md 20857, USA.

This paper compares cases of paralytic poliomyelitis reported to the systems operated by the National Vaccine Injury Compensation Program and the Centers for Disease Control and Prevention (CDC) for reporting of adverse events associated with vaccination. Of the 118 cases of vaccine-associated paralytic poliomyelitis determined by either system, 18 were reported initially only to the compensation program, 50 only to the CDC, and 50 to both. The annual incidence of vaccine-associated paralytic poliomyelitis determined from data from both systems varied from 6 to 13 cases (mean = 9.1) a year, with an increase of 1.4 cases a year when initial reports only to the compensation program are included. Thus, the compensation program provides important supplemental incidence data.




This article has been cited by other articles:


Home page
JAMAHome page
L. N. Alexander, J. F. Seward, T. A. Santibanez, M. A. Pallansch, O. M. Kew, D. R. Prevots, P. M. Strebel, J. Cono, M. Wharton, W. A. Orenstein, et al.
Vaccine Policy Changes and Epidemiology of Poliomyelitis in the United States
JAMA, October 13, 2004; 292(14): 1696 - 1701.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. M. Braun, G. T. Mootrey, M. E. Salive, R. T. Chen, S. S. Ellenberg, and the VAERS Working Group
Infant Immunization With Acellular Pertussis Vaccines in the United States: Assessment of the First Two Years' Data From the Vaccine Adverse Event Reporting System (VAERS)
Pediatrics, October 1, 2000; 106(4): 51e - 51.
[Abstract] [Full Text]


Home page
Int J EpidemiolHome page
L. H. de Oliveira and C. J. Struchiner
Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil
Int. J. Epidemiol., August 1, 2000; 29(4): 757 - 763.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Public Health Association